W. Stephens
Chief Tech/Sci/R&D Officer bei SHOCKWAVE MEDICAL, INC.
Profil
Derzeit ist W. Patrick Stephens Vice President-Research & Development von Shockwave Medical, Inc. In seiner früheren Laufbahn bekleidete er die Position des Vice President-Research & Development bei Endologix, Inc. und des Vice President-Product Development bei Trivascular Technologies, Inc. (eine Tochtergesellschaft von Endologix, Inc.). Herr Stephens erwarb einen Hochschulabschluss an der University of Arizona und einen Bachelor-Abschluss an der University of Colorado.
Aktive Positionen von W. Stephens
| Unternehmen | Position | Beginn |
|---|---|---|
| SHOCKWAVE MEDICAL, INC. | Chief Tech/Sci/R&D Officer | 01.07.2018 |
Ehemalige bekannte Positionen von W. Stephens
| Unternehmen | Position | Ende |
|---|---|---|
| ENDOLOGIX, INC. | Chief Tech/Sci/R&D Officer | 01.08.2018 |
| TRIVASCULAR TECHNOLOGIES INC | Corporate Officer/Principal | 01.02.2016 |
Ausbildung von W. Stephens
| University of Arizona | Graduate Degree |
| The University of Colorado | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHOCKWAVE MEDICAL, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA. | Health Technology |
Trivascular Technologies, Inc.
 Trivascular Technologies, Inc. Medical SpecialtiesHealth Technology Trivascular Technologies, Inc. operates as a medical device company developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company was founded on July 11, 2007 and is headquartered in Santa Rosa, CA. | Health Technology |
